Results 91 to 100 of about 2,002,341 (191)

Introduction to Issue on Yttrium-90 Radioembolization [PDF]

Techniques in Vascular and Interventional Radiology, 2019
openaire   +2 more sources

Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival

, 2016
The purpose of this study was to retrospectively assess the technical and clinical outcomes, overall survival and prognostic factors for prolonged survival after yttrium-90 ((90)Y) radioembolization as a salvage therapy for patients with chemorefractory ...
Van Cutsem, Eric, Haustermans, Karin, Maleux, Geert, Deroose, Christophe, Sagaert, Xavier, Aerts, Raymond, Topal, Baki, Vandecaveye, Vincent, Verslype, Chris, Vanbeckevoort, Dirk, De Hertogh, Gert, Laenen, Annouschka, Prenen, Hans, Heye, Sam   +13 more
core   +1 more source

Building a high-performing yttrium-90 radioembolization practice: from evidence to experience

CVIR Oncology
Yttrium-90 (90Y) radioembolization has evolved into a guideline-endorsed liver-directed therapy with curative, bridging, downstaging, and palliative applications in selected patients with hepatocellular carcinoma (HCC) and liver-dominant malignancies ...
Christopher Malone, Christopher Friend, Brittany Schmitt, Gary Siskin, Isabel Newton   +4 more
doaj   +1 more source

Complete Remission of Unresectable Hepatocellular Carcinoma after Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization

, 2016
Sorafenib has improved the median overall survival of unresectable or otherwise untreatable hepatocellular carcinoma (HCC) of ∼3 months, compared to supportive cares. Complete response, although rare, has been reported. The authors reported herein a case
Pravisani, Riccardo, Leo, Cosimo Alex, Soardo, Giorgio, RISALITI, Andrea, Bugiantella, Walter, Carnelutti, Alessia, BACCARANI, Umberto, Lorenzin, Dario   +7 more
core   +1 more source

Optimization of 99mTc-SPECT in the presence of 90Y for radioembolization

EJNMMI Physics
Background 99mTc-macroaggregated albumin (MAA) imaging is part of the standard work-up procedure for radioembolization using 90Y microspheres. In certain scenarios, it may be warranted to visualize the distribution of 99mTc in co-presence of 90Y, for ...
Camiel E.M. Kerckhaert, Martijn M.A. Dietze, Rob van Rooij, Marjolein B.M. Meddens, Niek Wijnen, Maarten L.J. Smits, Marnix G.E.H. Lam, Hugo W.A.M. de Jong   +7 more
doaj   +1 more source

Yttrium-90 Microsphere Radioembolization [PDF]

, 2020
openaire   +1 more source

Efficacy and safety of Y90 radioembolization combined with targeted therapy and immunotherapy in patients with unresectable hepatocellular carcinoma: a dual-center, retrospective study

BMC Cancer
Background Patients with unresectable hepatocellular carcinoma (uHCC) have a poor prognosis and limited treatment options. The combination of transarterial radioembolization (TARE) with yttrium-90 (Y90), targeted therapy, and immunotherapy represents a ...
Xiaolong Wang, Qinggui Jiang, Shiguang Chen, Yujie Li, Cheng Lin, Wenchang Yu, Weifu Liu, Linbing Qiu, Mingzhi Hao, Yinglang Zeng, Zhuting Fang   +10 more
doaj   +1 more source

Yttrium-90 Radioembolization

ACG Case Reports Journal, 2019
Estes, Derek J., Wideroff, Gina A., Sendzischew Shane, Morgan A., Sussman, Daniel A.   +3 more
openaire   +2 more sources

Transarterial Yttrium-90 Radioembolization Treatment of Patients with Liver-Dominant Metastatic Renal Cell Carcinoma

, 2017
Purpose: To evaluate safety and efficacy of transarterial hepatic radioembolization treatment of patients with liver-dominant metastatic renal cell carcinoma (RCC).
Sweeney, Jennifer, Kis, Bela, Hoffe, Sarah E., Shah, Jehan, Mellon, Eric, Biebel, Benjamin, Shridhar, Ravi, Choi, Junsung, Fishman, Mayer N., El-Haddad, Ghassan, Frakes, Jessica M.   +10 more
core   +1 more source

Knowledge mapping of ⁹⁰Y transarterial radioembolization combined with immunotherapy in hepatocellular carcinoma: a bibliometric analysis

Discover Oncology
Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with substantial mortality globally. The synergistic potential between immunotherapy and yttrium-90 transarterial radioembolization (⁹⁰Y-TARE) has stimulated extensive research into HCC ...
Song-Nian He, Chu-Hui Zeng, Rui-Jie Du, Yi-Xuan Yang, Hai-Dong Zhu   +4 more
doaj   +1 more source